Paper40314822
Synergistic pathogenesis: exploring biofilms, efflux pumps and secretion systems in Acinetobacter baumannii and Staphylococcus aureus.
Bell I PJ and 1 other. Arch Microbiol, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Synergistic pathogenesis: exploring biofilms, efflux pumps and secretion systems in Acinetobacter baumannii and Staphylococcus aureus. Papers, record 40314822. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40314822
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synergistic pathogenesis: exploring biofilms, efflux pumps and secretion systems in Acinetobacter baumannii and Staphylococcus aureus.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biofilms | Major topic |
| Acinetobacter baumannii | Major topic |
| Staphylococcus aureus | Major topic |
| Membrane Transport Proteins | Major topic |
| Humans | |
| Anti-Bacterial Agents | |
| Virulence Factors | |
| Staphylococcal Infections | |
| Drug Resistance, Multiple, Bacterial | |
| Cross Infection | |
| Bacterial Proteins | |
| Acinetobacter Infections |
Source PubMed
References77
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38097635 | Csu pili dependent biofilm formation and virulence of Acinetobacter baumannii. | NPJ Biofilms Microbiomes | 2023 | https://conductscience.org/library/papers/38097635 | PubMed |
| 2 | 32388085 | Regulatory networks important for survival of Acinetobacter baumannii within the host. | Curr Opin Microbiol | 2020 | https://conductscience.org/library/papers/32388085 | PubMed |
| 3 | 30174448 | Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. | Infect Drug Resist | 2018 | https://conductscience.org/library/papers/30174448 | PubMed |
| 4 | 38048840 | Anti-OmpA antibodies as potential inhibitors of Acinetobacter baumannii biofilm formation, adherence to, and proliferation in A549 human alveolar epithelial cells. | Microb Pathog | 2024 | https://conductscience.org/library/papers/38048840 | PubMed |
| 5 | 22609912 | Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii. | J Bacteriol | 2012 | https://conductscience.org/library/papers/22609912 | PubMed |
| 6 | 34343022 | The Type VII Secretion System of Staphylococcus. | Annu Rev Microbiol | 2021 | https://conductscience.org/library/papers/34343022 | PubMed |
| 7 | 31053906 | A Study on Acinetobacter baumannii and Staphylococcus aureus Strains Recovered from the Same Infection Site of a Diabetic Patient. | Curr Microbiol | 2019 | https://conductscience.org/library/papers/31053906 | PubMed |
| 8 | 33522395 | Pathogenicity and virulence of Staphylococcus aureus. | Virulence | 2021 | https://conductscience.org/library/papers/33522395 | PubMed |
| 9 | 36140042 | Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/36140042 | PubMed |
| 10 | 21173183 | Efflux-mediated antibiotic resistance in Acinetobacter spp. | Antimicrob Agents Chemother | 2011 | https://conductscience.org/library/papers/21173183 | PubMed |
| 11 | 34835457 | Impact of Healthcare-Associated Infections Connected to Medical Devices-An Update. | Microorganisms | 2021 | https://conductscience.org/library/papers/34835457 | PubMed |
| 12 | 34943714 | Efflux Pump Mediated Antimicrobial Resistance by Staphylococci in Health-Related Environments: Challenges and the Quest for Inhibition. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/34943714 | PubMed |
| 13 | 39617206 | Emergence of cefiderocol resistance during therapy in NDM-5-producing Klebsiella pneumoniae isolates harboring siderophore receptors mutations. | Int J Infect Dis | 2025 | https://conductscience.org/library/papers/39617206 | PubMed |
| 14 | 25422040 | Comparative analysis of surface-exposed virulence factors of Acinetobacter baumannii. | BMC Genomics | 2014 | https://conductscience.org/library/papers/25422040 | PubMed |
| 15 | 35618210 | In vitro activity of sulbactam-durlobactam against carbapenem-resistant Acinetobacter baumannii and mechanisms of resistance. | J Glob Antimicrob Resist | 2022 | https://conductscience.org/library/papers/35618210 | PubMed |
| 16 | 35149116 | Microbial resistance: The role of efflux pump superfamilies and their respective substrates. | Life Sci | 2022 | https://conductscience.org/library/papers/35149116 | PubMed |
| 17 | 35240900 | Nuclease activity: an exploitable biomarker in bacterial infections. | Expert Rev Mol Diagn | 2022 | https://conductscience.org/library/papers/35240900 | PubMed |
| 18 | 39414707 | Targeting PilA in Acinetobacter baumannii: A Computational Approach for Anti-Virulent Compound Discovery. | Mol Biotechnol | 2025 | https://conductscience.org/library/papers/39414707 | PubMed |
| 19 | 28373284 | Pathogenic Acinetobacter species have a functional type I secretion system and contact-dependent inhibition systems. | J Biol Chem | 2017 | https://conductscience.org/library/papers/28373284 | PubMed |
| 20 | 26033730 | Biofilm Formation Caused by Clinical Acinetobacter baumannii Isolates Is Associated with Overexpression of the AdeFGH Efflux Pump. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/26033730 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42410515 | Antimicrobial resistance profiles of ESKAPE pathogens isolated in a microbiology laboratory in Somalia: a two-year retrospective study. | BMC Infect Dis | 2026 | https://conductscience.org/library/papers/42410515 | PubMed |
| 42059665 | Synergistic effects of halo-plaque forming phage cocktails against polymicrobial Acinetobacter baumannii and Staphylococcus aureus. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/42059665 | PubMed |
| 41178132 | Antibiofilm activity of a chionodracine-derived peptide by NMR-based metabolomics of cell-free supernatant of Acinetobacter baumannii clinical strains. | FEBS Open Bio | 2026 | https://conductscience.org/library/papers/41178132 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40314822
GET https://conductscience.org/api/papers/v1/40314822/references?page=2